Physician profile
Robert Meuser
NPI 1972599082
$9,070.47
in general payments reported to CMS, 2019-2025
24 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $43.75 · 2021: $130 · 2022: $7,723 · 2023: $306 · 2024: $380 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,540.26 | 2019-2023 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $400.55 | 2019-2025 | Renasys Go V2 Home, Pico, Grafix Pl |
| Organogenesis INC. | $325.85 | 2022-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Abbvie INC. | $123.78 | 2021-2025 | |
| Cumberland Pharmaceuticals, INC. | $120.76 | 2019-2024 | Caldolor |
| Allergan, INC. | $77.34 | 2019-2020 | |
| Hartmann USA, INC. | $62.21 | 2022-2025 | Coactive Plus, Zetuvit Plus, Colactive Plus 2x2 |
| Ethicon US, LLC | $53.41 | 2022-2023 | Monocryl |
| Polynovo North America LLC | $44.71 | 2022-2024 | Novosorb Btm |
| Innovation Technologies INC | $34.85 | 2023 | Irrisept |
| Integra Lifesciences Corporation | $33.80 | 2019-2022 | |
| Lemaitre Vascular, INC. | $28.39 | 2023-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| W. L. Gore & Associates, INC. | $26.03 | 2023 | Gore Synecor Biomaterial |
| Avita Medical Americas, LLC | $25.89 | 2024 | |
| Avanos Medical | $24.10 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.21 | 2022 | |
| Innocoll Pharmaceuticals Limited | $19.12 | 2022 | |
| Acera Surgical, INC. | $17.79 | 2023 | Restrata Wound Matrix |
| Bioventus LLC | $16.62 | 2022 | |
| Braintree Laboratories, INC. | $16.05 | 2021 | |
| Melinta Therapeutics, LLC | $15.66 | 2019 | |
| Molnlycke Health Care US, LLC | $14.29 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Mimedx Group, INC. | $13.88 | 2025 | |
| Convatec INC. | $12.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Meuser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.